Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study

Real-world safety of linaclotide in Chinese patients with irritable bowel syndrome with constipation: a multicenter, single-arm, prospective observational study

Background: Linaclotide, a guanylate cyclase-C agonist, is indicated for irritable bowel syndrome with constipation (IBS-C). However, real-world data on the safety and patient-reported outcomes (PROs) of linaclotide are scarce in Chinese patients with IBS-C. Objectives: To assess the real-world safe...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yinglian Xiao, Xianmei Meng, Qingfeng Luo, Xiaohua Hou, Jie Jin, Xianfei Zhong, Wei Gong, Xiuling Li, Minhu Chen
Format:	Article
Language:	English
Published:	SAGE Publishing 2025-02-01
Series:	Therapeutic Advances in Gastroenterology
Online Access:	https://doi.org/10.1177/17562848251314819
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Serum salusin levels in diarrhea- and constipation-predominant irritable bowel syndrome
by: Elif Tugba Tuncel, et al.
Published: (2025-01-01)

Efficacy of linaclotide in combination with polyethylene glycol for bowel preparation in Chinese patients undergoing colonoscopy polypectomy: protocol for a randomised controlled trial
by: Jing Xu, et al.
Published: (2024-07-01)

On the Pathogenesis of the Irritable Bowel Syndrome: The Irritable Bowel or the Irritable Patient?
by: Stephen M Collins
Published: (1990-01-01)

Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01)

Discussion of the problem of functional constipation and irritable bowel syndrome in the reports of the International Congress on Neurogastroenterology and Motility (Bologna, 2012)
by: A. A. Sheptulin, et al.
Published: (2013-03-01)

Retracted: Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly
by: Emergency Medicine International
Published: (2024-01-01)

Treatment Algorithm for Chronic Idiopathic Constipation and Constipation-Predominant Irritable Bowel Syndrome Derived from a Canadian National Survey and Needs Assessment on Choices of Therapeutic Agents
by: Yvonne Tse, et al.
Published: (2017-01-01)

Subjective Taste and Smell Changes in Conjunction with Anxiety and Depression Are Associated with Symptoms in Patients with Functional Constipation and Irritable Bowel Syndrome
by: Jie Liu, et al.
Published: (2021-01-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

Discussion of irritable bowel syndrome issue and functional constipations in reports of the 21st United European Gastroenterological Week (Berlin, 2013)
by: A. A. Sheptulin, et al.
Published: (2014-09-01)

Bowel diseases and constipation in practice of the obstetrician and gynecologist
by: I. V. Kuznetsova, et al.
Published: (2015-03-01)

Esophageal lesions at irritable bowel syndrome
by: M. G. Mnatsakanyan, et al.
Published: (2015-10-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Motor Function in Irritable Bowel Syndrome
by: Michael Camilleri
Published: (1999-01-01)

Current Status of the Irritable Bowel Syndrome
by: Stephen M Collins
Published: (1999-01-01)

Effect of combined therapy by pinaverium bromide and itopride hydrochloride on clinical semiology and quality of life of patients with combination of constipation variant of irritable bowel syndrome and functional dyspepsia
by: O. V. Krapivnaya, et al.
Published: (2015-05-01)

Comparative efficacy of <i>Bifidobacterium bifidum, Bifidobacterium longum, Bifidobacterium infantis, Lactobacillus rhamnosus</i> composition and prucalopride in treatment of constipation variant of irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2015-07-01)

Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
by: Fang Yang, et al.
Published: (2021-01-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Socioeconomic Impact of Irritable Bowel Syndrome in Canada
by: Michel Boivin
Published: (2001-01-01)

The Role of Mast Cells in Irritable Bowel Syndrome
by: Kang Nyeong Lee, et al.
Published: (2016-01-01)

The Economic Burden of Irritable Bowel Syndrome in Canada
by: Judith D Bentkover, et al.
Published: (1999-01-01)

Role of Opioid Ligands in the Irritable Bowel Syndrome
by: Enrico Corazziari
Published: (1999-01-01)

Comment on “Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study”
by: Amin Talebi Bezmin Abadi
Published: (2016-01-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Treatment of irritable bowel syndrome: the past, present and future
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Long-term results of irritable bowel syndrome treatment
by: A. I. Ulyanin, et al.
Published: (2018-08-01)

Dysphoric spectrum of emotional disorders at irritable bowel syndrome
by: M. A. Morozova, et al.
Published: (2018-08-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Irritable bowel syndrome: an approach for primary care physicians
by: Zhi En Tan, et al.
Published: (2022-07-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

A European Approach to Irritable Bowel Syndrome Management
by: Michel Delvaux, et al.
Published: (1999-01-01)

Peripheral Mechanisms of Symptom Generation in Irritable Bowel Syndrome
by: Stephen M Collins
Published: (2001-01-01)

A Canadian Perspective on the Management of Irritable Bowel Syndrome
by: Stephen M Collins
Published: (2001-01-01)

Persistence of gastrointestinal symptoms in irritable bowel syndrome and ulcerative colitis: study protocol for a three-arm randomised controlled trial (SOMA.GUT-RCT)
by: Ansgar W Lohse, et al.
Published: (2022-06-01)